Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cerilliant
Julphar
Deloitte
Cantor Fitzgerald
Fuji
Chubb
UBS
Cipla

Generated: April 19, 2018

DrugPatentWatch Database Preview

Crisaborole - Generic Drug Details

« Back to Dashboard

What are the generic sources for crisaborole and what is the scope of crisaborole freedom to operate?

Crisaborole
is the generic ingredient in one branded drug marketed by Anacor Pharms Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Crisaborole has one hundred and eleven patent family members in twenty-two countries.

One supplier is listed for this compound.
Summary for crisaborole
International Patents:111
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 49
Clinical Trials: 4
Patent Applications: 40
Drug Prices:see low prices
DailyMed Link:crisaborole at DailyMed
Pharmacology for crisaborole
Synonyms for crisaborole
1073669-75-6
1187189-21-4
4-((1-HYDROXY-1,3-DIHYDROBENZO-[C][1,2]OXABOROL-5-YL)OXY)BENZONITRILE
4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile
4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile
4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile
4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile
4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile
5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole
5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole
5098AC
906673-24-3
ABP001114
AK102641
AKOS016005425
AN 2728
AN-2728
AN2728
ANW-65536
API0013781
AX8234180
BC245091
BDBM50277665
Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-
Benzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-
C14H10BNO3
CHEBI:134677
CHEMBL484785
compound 5b [PMID: 19303290]
Crisaborole (USAN/INN)
Crisaborole [USAN:INN]
Crisaborole topical ointment 2%
Crisaborole, >=98% (HPLC)
Crisaborole(AN-2728)
CS-1057
CTK8C0958
D0SM0W
D10873
DB-078771
DB05219
DTXSID10238231
Eucrisa
Eucrisa (TN)
EX-A1087
FT-0767999
GTPL9151
HE053309
HE268247
HY-10978
KB-40872
KS-0000063U
MFCD17169940
MolPort-023-332-548
NCGC00345792-01
Q2R47HGR7P
SCHEMBL595261
ST24042710
TC-154281
UNII-Q2R47HGR7P
USZAGAREISWJDP-UHFFFAOYSA-N
W-5676
ZINC169748244

US Patents and Regulatory Information for crisaborole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for crisaborole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,582,621 Boron-containing small molecules ➤ Try a Free Trial
7,767,657 Boron-containing small molecules ➤ Try a Free Trial
9,029,353 Boron-containing small molecules as anti-inflammatory agents ➤ Try a Free Trial
9,566,289 Boron-containing small molecules ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
AstraZeneca
Daiichi Sankyo
Teva
Johnson and Johnson
McKesson
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.